DS
LUNG icon

David Shaw’s Pulmonx LUNG Stock Holding History

David Shaw’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426K Sell
327,528
-7,546
-2% -$10.4K ﹤0.01% 4260
2026
Q1 		$432K Sell
335,074
-226,192
-40% -$374K ﹤0.01% 3924
2025
Q4 		$1.24M Sell
561,266
-227,983
-29% -$429K ﹤0.01% 3392
2025
Q3 		$1.28M Buy
789,249
+299,369
+61% +$626K ﹤0.01% 3299
2025
Q2 		$1.27M Buy
489,880
+3,325
+0.7% +$13.1K ﹤0.01% 3068
2025
Q1 		$3.27M Buy
486,555
+93,719
+24% +$664K ﹤0.01% 2222
2024
Q4 		$2.67M Buy
392,836
+32,049
+9% +$211K ﹤0.01% 2503
2024
Q3 		$2.99M Sell
360,787
-18,231
-5% -$132K ﹤0.01% 2379
2024
Q2 		$2.4M Sell
379,018
-52,279
-12% -$402K ﹤0.01% 2493
2024
Q1 		$4M Sell
431,297
-191,291
-31% -$2.24M ﹤0.01% 2063
2023
Q4 		$7.94M Sell
622,588
-45,770
-7% -$477K 0.01% 1547
2023
Q3 		$6.9M Sell
668,358
-48,020
-7% -$556K 0.01% 1551
2023
Q2 		$9.39M Buy
716,378
+142,214
+25% +$1.74M 0.01% 1390
2023
Q1 		$6.42M Buy
574,164
+320,174
+126% +$3.16M 0.01% 1734
2022
Q4 		$2.14M Buy
+253,990
New +$2.42M ﹤0.01% 2889
2021
Q2 		– Sell
-23,636
Closed -$1.08M – 4898
2021
Q1 		$1.08M Buy
+23,636
New +$1.36M ﹤0.01% 3053

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

David Shaw's LUNG Position: Q2 2026 in Review

David Shaw reduced its Pulmonx (LUNG) stake by 2.3% in Q2 2026, selling an estimated $10.4K and leaving 327,528 shares worth $426K. The position accounts for ﹤0.01% of the portfolio, ranked #4260.

David Shaw first reported a position in LUNG in Q1 2021 and has held it in 16 quarters since. The position peaked at $9.39M in Q2 2023. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • David Shaw held 327,528 shares of Pulmonx worth $426K as of Q2 2026.
  • David Shaw sold 7,546 Pulmonx shares in Q2 2026, an estimated $10.4K.
  • Pulmonx made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4260 holding.
  • David Shaw first reported a position in Pulmonx in Q1 2021 and has held it in 16 quarters since.
  • David Shaw's Pulmonx position peaked at $9.39M in Q2 2023.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.